Research Article
Characterization of the Gene Expression Profile of Human Hippocampus in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Table 1
Clinical history, MRI findings, pathological diagnosis, and postoperative outcome of 10 patients who underwent selective amygdalohippocampectomy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AEDs: antiepileptic drugs; CBZ: carbamazepine; LEV: levetiracetam; LTG: lamotrigine; PHT: phenytoin; TPM: topiramate; GP: gabapentin; PB: phenobarbital; OXC: oxcarbazepine; VPA: valproic acid. SPS: simple partial seizures; CPS: complex partial seizures; SGS: secondary generalized seizures. aImmunohistochemistry. bOne-cycle target labelling gene array. cQuantitative real-time RT-PCR (TaqMan). dBrain-derived microvascular endothelial cells (MVECs). eTwo-cycle target labeling gene array. fWyler classification was not determined in all cases. MTS, mesial temporal sclerosis. |